IP Library Granted Patent US 7,250,272
Granted Patent B2
US 7,250,272 · App. 10/398,870 · Granted Jul 31, 2007

G protein-coupled receptor protein and DNA thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,250,272
App. No.
10/398,870
Granted
Jul 31, 2007
Kind
B2
Abstract

The present invention aims at providing a useful and novel G protein-coupled receptor protein and DNA thereof. The G protein-coupled receptor protein of the present invention and the like, and the polynucleotides encoding the receptor protein and the like, are useful for; 1) determination of ligands (agonists); 2) preparation of antibodies and antisera; 3) construction of recombinant receptor protein expression systems; 4) development of the receptor binding assay systems using the expression systems and screening of pharmaceutical candidate compounds; 5) effecting drug design based on comparison with structurally similar ligand receptors; 6) reagents for preparation of probes and PCR primers for gene diagnosis; 7) production of transgenic animals; and 8) pharmaceutical drugs for the gene prophylaxis and gene therapy.

Claims (20)

1. An isolated G protein-coupled receptor protein having the amino acid sequence of SEQ ID NO: 3, or a salt thereof.

2. A method of manufacturing the isolated G protein-coupled receptor protein or its salt according to claim 1 which comprises culturing a host cell transformed with an expressible recombinant vector encoding for said protein for sufficient time and under conditions to produce said protein, and producing the G protein-coupled receptor protein according to claim 1 .

3. An isolated polynucleotide containing a polynucleotide encoding the amino acid sequence of SEQ ID NO: 3.

4. An isolated polynucleotide according to claim 3 , which is DNA.

5. An isolated DNA according to claim 4 , having the nucleic acid sequence of SEQ ID NO: 4.

6. A recombinant vector containing the isolated polynucleotide according to claim 3 .

7. A transformed host cell which has been transformed with the recombinant vector according to claim 6 .

8. A diagnostic product comprising the polynucleotide according to claim 3 .

9. The diagnostic product according to claim 8 , which is a diagnostic product for colon cancer.

10. A diagnostic product, which comprises combining (i) the polynucleotide according to claim 3 and (ii) a polynucleotide encoding the amino acid sequence represented by SEQ ID NO: 16, or a polynucleotide encoding a G protein coupled receptor protein having an amino acid sequence represented by SEQ ID NO: 18.

11. The diagnostic product according to claim 10 , which is a diagnostic product for colon cancer.

12. A diagnostic method, which comprises measunng an expression level of a G protein coupled receptor protein having the amino acid sequence of SEQ ID NO: 3, or its salt by using a polynucleotide according to claim 3 said method comprising quantifying mRNA encoding for said proteins using said polynucleotide.

13. The diagnostic method according to claim 12 , which is a diagnostic method for colon cancer.

14. A method of determining a ligand to a G protein-coupled receptor protein with the amino acid sequence of SEQ ID NO: 3, or a salt thereof, which comprises using the G protein-coupled receptor protein or salts thereof in an assay comprising combining a test ligand with said protein, and determining the amount of binding of said test ligand to said protein.

15. A method of screening a compound that alters the binding property between a ligand and the G protein-coupled receptor protein with the amino acid sequence of SEQ ID NO: 3, or a salt thereof, in a screening assay which comprises i) contacting the G protein-coupled receptor protein or salt thereof with a ligand; ii) contacting the G protein-coupled receptor protein or salt thereof with a ligand and a test compound; iii) determining the amount of ligand bound in i) and ii); iv) comparing the values obtained.

16. A kit for screening a compound that alters the binding property between a ligand and the G protein-coupled receptor protein with the amino acid sequence of SEQ ID NO: 3, or a salt thereof, which comprises the G protein-coupled receptor protein, or salts thereof in an assay.

17. A diagnostic product, which comprises combining a polynucleotide containing a polynucleotide containing a base sequence represented by SEQ ID NO: 2 and a polynucleotide containing a base sequence represented by SEQ ID NO: 4.

18. The diagnostic product according to claim 17 , which is a diagnostic product for colon cancer.

19. A diagnostic method for colon cancer which comprises measuring an expression level of an isolated G protein coupled receptor protein having the amino acid sequence of SEQ ID NO: 3 or its salt, by using a polynucleotide containing a polynucleotide containing a base sequence represented by SEQ ID NO: 2, and a polynucleotide containing a polynucleotide containing a base sequence represented by SEQ ID NO: 4 said method comprising quantifying mRNA encoding for said isolated protein using said polynucleotides.

20. The diagnostic method according to claim 19 , which is used for diagnosing colon cancer.

Assignments (2)
CHANGE OF NAME Recorded Jun 17, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016914/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2003
From: SATO, SYUJI; SHINTANI, YASUSHI; MIYAJIMA, NOBUYUKI; YOSHIMURA, KOJI
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 014436/0067 →